Together, we create a future of hope and healing.
At Hiba Pharma, we are committed to excellence in oncology pharmaceutical manufacturing. Through cutting-edge technology, rigorous quality standards, and innovative research, we develop life-saving cancer treatments that improve patient outcomes.
With a focus on precision, compliance, and accessibility, we strive to set new benchmarks in oncology care. Our mission is clear: to advance pharmaceutical quality and enrich lives by providing safe, effective, and reliable therapies for those who need them most.
our journey
Launched UAE-based operations with a strategic focus on oncology manufacturing.
Established business office at Dubai Science Park.
Licensing & Tech transfer agreements with Kelix Bio and Novugen Pharma.
Ground breaking in KEZAD, Abu Dhabi.
Licensing & Tech Transfer agreement with SAKAR Healthcare.
Civil and structural work.
MEP and commissioning.
Facility inauguration and EDE cGMP approval.
Tech transfer Phase.
GMP inspections GCC, SFDA.
Established business office at Dubai Science Park.
Ground breaking in KEZAD, Abu Dhabi.
Civil and structural work.
MEP and commissioning.
GMP inspections GCC, SFDA.
Our facility
HIBA Pharma takes pride in operating state-of-the-art manufacturing facility in in Kezad, Abu Dhabi, UAE, equipped with the latest industry technologies.
Our facility is being built to comply with cGMP regulations and international standards, ensuring the highest safety, efficacy, and quality standards in every product we manufacture.
We are proud to be the only local facility producing sterile injectable oncology medications. We stand at the forefront of pharmaceutical advancements, reinforcing our commitment to addressing unmet medical needs.
Our Portfolio
HIBA Pharma is dedicated to provide high-quality pharmaceutical solutions that address critical healthcare challenges. Our diverse product portfolio spans multiple therapeutic categories that include but not limited to:
Our partners
HIBA PHARMA actively seeks partnerships with forward-thinking pharmaceutical firms that share our commitment to innovation, quality, and patient-centric approach through Licensing, Technology Transfer and Contract Manufacturing.
LATEST NEWS
Rso bonus privato di fondo consentono di controllare il confusione in assenza di corrispettivo di contante
Reiteratamente si https://fezbet-casino.it.com/ tratta di maggiorazioni di pochi decimi, ad esempio eppure nel diluito minuto possono eleggere la differenza ancora allettare tanto nuovi fruitori. I
Context and Initial Situation
Mel Bet has emerged as a significant player in the online gambling world, thanks to its user-friendly interface and a robust slate of betting options.
LATEST NEWS
Associarsi di nuovo preparare a divertirsi nei casa da gioco online stranieri sicuri e indivisible fascicolo chiaro di nuovo veloce
Nei trambusto online esteri puoi giungere a categorie di giochi ad esempio i crash games, gli instant games ad alta volatilita ovverosia quelli mediante RTP
Launched UAE-based operations with a strategic focus on oncology manufacturing. Established business office at Dubai Science Park.
Licensing & Tech transfer agreements with Kelix Bio and Novugen Pharma. Ground breaking in KEZAD, Abu Dhabi.
Licensing & Tech Transfer agreement with SAKAR Healthcare. Civil and structural work.
MEP and commissioning.
Facility inauguration and EDE cGMP approval. Tech transfer Phase. GMP inspections GCC, SFDA.
